Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT06963775Not Yet Recruiting

Assessment of Traumatic Brain Injury Using Transcranial Magnetic Stimulated Evoked Potentials

Role: collaborator

NCT06368024Completed

Establishment of Delphi-MD Safety Performance and Reliability

Role: lead

NCT03884647Completed

DELPHI in Subjects at Risk for Stroke and Dementia

Role: lead

NCT03842345Withdrawn

DELPhI Evaluation of Psychiatric Conditions

Role: lead

NCT04095377Completed

Development of Automated Analysis to Electroencephelogram (EEG) Data in Patients Treated at the Sagol Hyperbaric Medicine and Research Center at the Years 2017-2019.

Role: lead

NCT03832413Completed

Characterization of the DELPhI System in Assessing Brain's Functionality in Different Neurological Disorders

Role: lead

All 6 trials loaded